Factors That Effect the Gait Speed in Diabetic Individuals Without Neuropathy

NCT04758364 | Completed

• 1 other identifier: 60116787-020/75097
• Study Type: observational
• Target: 71
• Locations: 1 country
• Sites: 1

Brief Summary

This study planned to investigate the role of potential explanatory factors effecting the speed of gait such as muscle mass, aerobic capacity, physical activity status, cognitive function, blood pressure, and metabolic measures considering age, sex, and education years in diabetic individuals without neuropathy.

Conditions

Gait Disorder, Sensorimotor; Diabetes Mellitus, Type 2

Keywords

Mini-Mental State Examination; gait; aerobic capacity; HbA1c; muscle; hypertension; glucose

Outcome Measures

Primary Outcomes (1)

• gait speed

  gait speed measured by wearable accelerometer

  The gait speed will be measured once within a month after the participants enrolled.

Interventions

measurement of gait speed OTHER

Cross sectional, cohort

Also known as: measurement of aerobic capacity, measurement of muscle mass, measurement of blood glucose and HbA1c, cognitive function testing, physical activity questioning, blood pressure measurement

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Type 2 Diabetic individuals without neuropathy

You may qualify if:

• Individuals with Diabetes Mellitus less than 10 years but longer than 1 year
• Absence of neuropathic symptoms
• DN4 questionnaire sore less than 4

You may not qualify if:

• Individuals who had
• insulin therapy,
• poor glycemic control,
• manifesting cardiovascular disease,
• retinopathy or other visual problems,
• diabetic neuropathy,
• nephropathy,
• cerebrovascular disease,
• cognitive impairment,
• heart failure,
• alcohol or cigarette dependence,
• cancer,
• chemo/radiotherapy,
• foot ulcer,
• orthopedical or surgical problems

Sponsors & Collaborators

• GULIN FINDIKOGLU: lead

Study Sites (1)

Pamukkale University

Denizli, 21600, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Gait Disorders, Neurologic; Diabetes Mellitus, Type 2; Hypertension

Condition Hierarchy (Ancestors)

Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Diabetes Mellitus; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Vascular Diseases; Cardiovascular Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 1 Month
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Assoc Proffessor, MD, PhD

Study Record Dates

• First Submitted: February 11, 2021
• First Posted: February 17, 2021
• Study Start: February 20, 2021
• Primary Completion: March 12, 2021
• Study Completion: March 30, 2021
• Last Updated: April 1, 2021

Record last verified: 2021-03

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)